Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
10/30/2014 | US20140322249 Dna vaccines against tumor growth and methods of use thereof |
10/30/2014 | US20140322248 Dual Specific Immunotoxin for Brain Tumor Therapy |
10/30/2014 | US20140322242 Materials and methods for the prevention and treatment of cancer |
10/30/2014 | US20140322240 Malaria vaccine |
10/30/2014 | US20140322237 Neurodegenerative diseases and methods of modeling |
10/30/2014 | US20140322233 Anti-gcc antibody molecules and related compositions and methods |
10/30/2014 | US20140322232 Methods of administering anti-tnfalpha antibodies |
10/30/2014 | US20140322230 Induction of mucosal tolerance to antigens |
10/30/2014 | US20140322225 Anti-Adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-Ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation |
10/30/2014 | US20140322221 Multivalent antibodies and uses therefor |
10/30/2014 | US20140322220 Anti-FGFR2 Antibodies and Uses Thereof |
10/30/2014 | US20140322213 Pharmaceutical Composition for the Treatment of Type-1 Diabetes |
10/30/2014 | US20140322208 Treatment of hematologic malignancies with an anti-cxcr4 antibody |
10/30/2014 | US20140322207 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof |
10/30/2014 | US20140322203 Formulations with reduced oxidation |
10/30/2014 | US20140322202 TREATMENT WITH ANTI ErbB2 ANTIBODIES |
10/30/2014 | US20140322201 Methods of treating multiple myeloma using combination therapies based on anti-cs1 antibodies |
10/30/2014 | US20140322200 Combination therapy of an afucosylated cd20 antibody with an anti-vegf antibody |
10/30/2014 | US20140322163 Neutralizing antibodies to hiv-1 and their use |
10/30/2014 | US20140322161 Anti-il-6 vaccine composition |
10/30/2014 | US20140322160 Method and composition for altering a b cell mediated pathology |
10/30/2014 | US20140322134 Treatment and Imaging Methods Using Antibodies to Aminophospholipids |
10/30/2014 | US20140322131 Methods and Agents for the Diagnosis and Treatment of Hepatocellular Carcinoma |
10/30/2014 | US20140322130 Specific binding proteins and uses thereof |
10/28/2014 | US8871911 Compositions and methods for the diagnosis and treatment of tumor |
10/28/2014 | US8871908 Antibodies specific for Trop-2 and their uses |
10/28/2014 | US8871902 Immunogenic POTE peptides and methods of use |
10/28/2014 | US8871901 Phage constructs, sequences and antigenic compositions for immunocontraception of animals |
10/28/2014 | US8871816 Methods for producing vaccine adjuvants |
10/28/2014 | US8871732 Immunostimulatory sequence oligonucleotides and methods of using the same |
10/28/2014 | US8871729 Treatment of CNS conditions |
10/28/2014 | US8871725 Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs |
10/28/2014 | US8871719 Modified MELK peptides and vaccines containing the same |
10/28/2014 | US8871708 Compositions and methods for treating AIDS or cancer by inhibiting the secretion of microparticles |
10/28/2014 | US8871491 Capsular gram-positive bacteria bioconjugate vaccines |
10/28/2014 | US8871487 Compositions, methods and uses for inducing viral growth |
10/28/2014 | US8871467 Polynucleotides encoding antibodies that bind both IL-17A and IL-17F |
10/28/2014 | US8871447 Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |
10/28/2014 | US8871436 Immunostimulatory oligonucleotides and uses thereof |
10/28/2014 | US8871250 Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine |
10/28/2014 | US8871226 Methods and compositions for the treatment and diagnosis of cancer |
10/28/2014 | US8871225 Canine leishmania vaccine |
10/28/2014 | US8871224 Botulinum toxin therapy for skin disorders |
10/28/2014 | US8871223 HSV-1 and HSV-2 vaccines and methods of use thereof |
10/28/2014 | US8871222 Recombinant Flavivirus vaccines |
10/28/2014 | US8871221 Methods of stimulating protective immunity employing Dengue viral antigens |
10/28/2014 | US8871220 Newcastle disease virus vectored avian vaccines |
10/28/2014 | US8871219 Recombinant vectors based on the modified vaccinia ankara virus (MVA) as preventive and therapeutic vaccines against AIDS |
10/28/2014 | US8871216 Multiple signaling pathways induced by hexvalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases |
10/28/2014 | US8871215 Flagellin related polypeptides and uses thereof |
10/28/2014 | US8871214 Detoxified Escherichia coli immunogens |
10/28/2014 | US8871213 Prevention, treatment and diagnosis of P. gingivalis infection |
10/28/2014 | US8871212 Amyloid-beta polypeptide vaccine |
10/28/2014 | US8871211 Cancer vaccines and vaccination methods |
10/28/2014 | US8871209 Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or Activin A |
10/28/2014 | US8871207 Neutralizing anti-influenza A virus antibodies and uses thereof |
10/28/2014 | US8871205 Methods and compositions for the treatment of immune disorders |
10/28/2014 | US8871203 Method of treating a pathological syndrome and a pharmaceutical agent |
10/28/2014 | US8871202 Prevention and treatment of pain using antibodies to sphingosine-1-phosphate |
10/28/2014 | US8871201 Stabilizing formulations |
10/28/2014 | US8871199 Compositions and methods to promote implantation and engrafment of stem cells |
10/28/2014 | US8871193 Viral vectors and their use in therapeutic methods |
10/28/2014 | US8871192 IL-1F8 polypeptides |
10/23/2014 | US20140316111 Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines |
10/23/2014 | US20140316110 Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines |
10/23/2014 | US20140315314 Engineered listeria and methods of use thereof |
10/23/2014 | US20140314865 Vaccine Nanotechnology |
10/23/2014 | US20140314858 Ipnv-isav bivalent vaccine using a virus-like particle-based platform and methods of using the same |
10/23/2014 | US20140314852 Nanoparticulate systems prepared from sorbitan esters |
10/23/2014 | US20140314839 Controlled-release peptide compositions and uses thereof |
10/23/2014 | US20140314837 Vaccine Therapy |
10/23/2014 | US20140314834 Gla monotherapy for use in cancer treatment |
10/23/2014 | US20140314816 Stabilized stat3 decoy oligonucleotides and uses therefore |
10/23/2014 | US20140314814 Antigen presenting cancer vaccine |
10/23/2014 | US20140314813 Clostridium difficile lipoteichoic acid and uses thereof |
10/23/2014 | US20140314812 Live, attenuated streptococcus pneumoniae strain and vaccine for protection against pneumococcal disease |
10/23/2014 | US20140314811 Herpes simplex virus vaccines |
10/23/2014 | US20140314810 Compositions Containing Purine and Pyrimidine Nucleosides, Peptides, and Manganese and Their Uses |
10/23/2014 | US20140314807 Reverse genetics Schmallenberg virus vaccine compositions, and methods of use thereof |
10/23/2014 | US20140314806 Potency test for vaccine formulations |
10/23/2014 | US20140314805 Multivalent pneumococcal polysaccharide-protein conjugate composition |
10/23/2014 | US20140314804 Compositions including beta-glucans and methods of use |
10/23/2014 | US20140314803 Compositions and methods related to p6 |
10/23/2014 | US20140314802 Novel compositions and methods |
10/23/2014 | US20140314800 Beta-lactoglobulin peptides for treating cow's milk protein allergy |
10/23/2014 | US20140314799 Methods, agents and peptides for inhibiting matrix metalloproteinase-2 signaling |
10/23/2014 | US20140314791 Methods of treating cancer |
10/23/2014 | US20140314784 Anti-cxcr4 antibodies and methods of use |
10/23/2014 | US20140314783 Methods for suppressing allergic reactions |
10/23/2014 | US20140314781 Formulation of human antibodies for treating tnf-alpha associated disorders |
10/23/2014 | US20140314780 Compositions Using Antibodies Directed to GPNMB and Uses Thereof |
10/23/2014 | US20140314778 Formulations with reduced oxidation |
10/23/2014 | US20140314776 Method of treating alveolar bone loss through the use of anti-sclerostin antibodies |
10/23/2014 | US20140314775 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment of anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease |
10/23/2014 | US20140314774 Her3 antibodies and uses thereof |
10/23/2014 | US20140314773 Compositions and methods for treating alzheimer's disease |
10/23/2014 | US20140314771 Combination therapy of antibodies against human csf-1r and tlr9 agonist |
10/23/2014 | US20140314769 Neutralizing Antibodies And Methods Of Use Thereof |
10/23/2014 | US20140314764 Bi-specific antibodies for medical use |
10/23/2014 | US20140314762 Stimulation of Ovarian Follicle Development and Oocyte Maturation |